Bio-Techne Corporation

NASDAQ:TECH

Biotechnology

Healthcare
$72.75 -1.84%

-$1.03 today

Market cap
$11.43B
Beta
1.36
P/E (TTM)
78.3
EPS (TTM)
$0.70
Dividend yield
0.58%
52W Low $43.20High $72.16

Volume 2.63M

Average 2.66M

TECH Short-term Debt

Borrowings and the current portion of long-term debt due within one year.

Bio-Techne CorporationNASDAQ: TECH

Short-term Debt · Q1 FY2027 · quarter ended Sep 2026

Short-term debt remains negative

Q1 FY2027 short-term debt was $200M, compared with $0 a year earlier.

Context

  • Short-term debt amounted to 7.6% of total assets at the end of Q1 FY2027, up 7.6 pp from a year earlier.
  • Short-term debt increased in 1 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$200M— QoQ
Last fiscal yearJun 2026
$14.94M— YoY
Year agoSep 2025
$0— since
Short-term Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Short-term Debt history

USD · from the balance sheet

Latest · FY2026
14.94M USD
Year-over-year change
—
4-year CAGR
+4.5%

Short-term Debt vs competitors

How TECH compares with its peers on the latest reported figures

  • TECH's Sep 2026 short-term debt of $200M is the 6th highest of the 11 companies compared; the peer median is $202.5M.
  • Short-term debt amounts to 7.6% of total assets for TECH, versus a peer median of 1.8%.
TECH Competitors Peer median
Short-term Debt for TECH and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TMOThermo Fisher Scientific Inc.Sep 2026$2.26B -40.8%-15.5%2.0%
DHRDanaher CorporationSep 2026$2.09B +9004.3%-86.2%2.2%
RVTYRevvity, Inc.Jul 2026$572.16M +248663.5%+7.7%4.7%
BIOBio-Rad Laboratories, Inc.Jun 2026$400.7M +30723.1%+333.6%3.9%
AAgilent Technologies, Inc.Jul 2026$304M +415.3%+103.6%2.2%
TECHBio-Techne CorporationSep 2026$200M ——7.6%
BRKRBruker CorporationJun 2026$101M +81.3%+40.4%1.7%
QGENQiagen N.V.Jun 2026$16.52M -97.0%—0.3%
TXG10x Genomics, Inc.Sep 2026$11.95M +13.3%—1.1%
ALMRAlamar Biosciences, Inc.Jun 2026$2.28M ——0.6%
SEERSeer, Inc.Mar 2026$0 -100.0%—0.0%
Peer median (excluding TECH) $202.5M+81.3%+24.1%1.8%

Competitors are the stored peer set for TECH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Cash & Equivalents172.57M180.57M151.79M162.19M264.71M
Short-term Investments74.46M23.74M1.07M00
Net Receivables194.55M218.47M241.39M206.88M220.5M
Inventory141.12M171.64M179.73M189.45M195.74M
Other Current Assets22.86M27.07M43.43M49.79M63.45M
Total Current Assets605.56M621.48M617.42M608.3M744.4M
Property, Plant & Equipment (Net)288.8M324.53M342.44M319.12M299.17M
Goodwill822.1M872.74M972.66M980.94M975.36M
Intangible Assets531.52M534.65M507.08M365.6M303.47M
Long-term Investments0255.86M242.34M250.98M253.39M
Tax Assets00010.31M92.27M
Other Non-current Assets46.83M29.45M21.93M22.63M10.95M
Total Non-current Assets1.69B2.02B2.09B1.95B1.93B
Total Assets2.29B2.64B2.7B2.56B2.68B
Account Payables33.87M25.68M37.97M25.31M26.7M
Short-term Debt12.5M00014.94M
Tax Payables13.24M12.02M3.71M10.77M0
Deferred Revenue23.41M23.07M27.93M32.57M36.07M
Other Current Liabilities1.24M1.41M2.15M1.65M24.48M
Total Current Liabilities176.02M128.51M159.38M175.85M163.7M
Long-term Debt243.41M350M319M346M200M
Deferred Tax Liabilities98.99M88.98M55.86M6.17M111.57M
Deferred Revenue (Non-current)00002.33M
Other Non-current Liabilities17.24M10.92M13.16M27.08M19.02M
Total Non-current Liabilities417.78M543.67M475.64M463.21M407.07M
Total Liabilities593.79M672.18M635.02M639.06M570.77M
Common Stock1.57M1.58M1.58M1.55M1.56M
Retained Earnings1.12B1.31B1.33B1.07B1.14B
Accumulated OCI(75.2M)(66.06M)(78.32M)(59.88M)(70.58M)
Other Stockholders Equity00000
Minority Interest(759K)0000
Total Equity1.7B1.97B2.07B1.92B2.11B
Total Debt325.97M454.97M419.54M444.06M289.09M
Net Debt153.4M274.39M267.75M281.87M24.38M

Bio-Techne Corporation

NASDAQ:TECH

Intrinsic Alpha fair value

Locked

Current Price

$72.75

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.